Documentos de I. Howland-Álvarez | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Área de conocimiento: "Farmacología"

Subtipo de publicación

Publisher

Biotecnologia Aplicada(2)

BMC Pharmacology and Toxicology(1)

Área temáticas

Farmacología y terapéutica(3)

Enfermedades(2)

Problemas sociales y servicios a grupos(1)

Temas específicos de historia natural de los animales(1)

Área de conocimiento

Año de Publicación

Origen

Palabras Claves

2'-5' oligoadenylate synthetase(1)

Beta2-microglobulin(1)

Carbon tetrachloride(1)

Cytoprotection(1)

Growth Hormone Releasing Peptide 6 (GHRP6) reduces liver fibrosis in CCl4 chronically intoxicated rats

Abstract: Tissue fibrosis is a leading cause of morbidity and mortality. Current treatments for conditions suc

Palabras claves:

Carbon tetrachloride, Cirrhosis, Cytoprotection, FIBROSIS, GHRP6, Liver, Secretagogue

Abreu A., Berlanga-Acosta J., Bringas R., Cibrín D., Cintado A., Coro-Antich R., Cosme-Díz K., Cruz Y., Fernández-Massó J.R., García-del Barco D., González-Ferrer Y., Guillén I., Guillén-Nieto G.E., I. Howland-Álvarez, Inés L., Ivón Howland-Álvarez, León-Fernández O.S., López-Mola E., Mendoza-Marí Y., Miranda J., Nazabal M., Ochagavía M.E., Palenzuela D., Suaréz J., Ugarte-Moreno D., Vázquez-Blomquist D., Vila J.M.

Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers

Abstract: Background: More potent antitumor activity is desired in Interferon (IFN)-treated cancer patients. T

Palabras claves:

2'-5' oligoadenylate synthetase, Beta2-microglobulin, interferons, Neopterin, pharmacodynamics, pharmacokinetics

Bello-Rivero I., Campos-Mojena R., Cruz-Ramírez A., Díaz-Machado A., García-Vega Y., González-Delgado C.A., Hernández-González I., I. Howland-Álvarez, López-Saura P.A., Martín-Trujillo A., Pérez-Rodríguez S., Santana-Milián H., Tuero-Iglesias Á.D., Valenzuela-Silva C.M.

Preclinical safety demonstration of the human recombinant erythropoietin HEBERITRO®

Abstract: Erythropoietin (EPO) is a glycoprotein that appears in blood as a response to hypoxia, acting on bon

Palabras claves:

EPREX®, erythropoietin, Preclinical toxicology, safety

Bacardí D.M., Cosme K., Gutiérrez A., I. Howland-Álvarez, Ivón Howland-Álvarez, Merino N., Pérez-Caballero M., Porras D.N., Suaréz J., Urquiza D., Vázquez A.